TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T62548	Beta-adrenergic receptor kinase 1	B9WK4G	N-[(2-Chlorophenyl)methyl]-3-[(3-pyridin-4-yl-1H-1,2,4-triazol-5-yl)methylamino]benzamide	Investigative	137650510	C22H19ClN6O	418.9	C1=CC=C(C(=C1)CNC(=O)C2=CC(=CC=C2)NCC3=NC(=NN3)C4=CC=NC=C4)Cl	EC50 = 120000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BC80IJ	N-[(2-Methoxyphenyl)methyl]-3-[(3-pyridin-4-yl-1H-1,2,4-triazol-5-yl)methylamino]benzamide	Investigative	137654557	C23H22N6O2	414.5	COC1=CC=CC=C1CNC(=O)C2=CC(=CC=C2)NCC3=NC(=NN3)C4=CC=NC=C4	EC50 = 76000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BC82AY	Acetic acid, methoxy-, 2-(1H-indol-2-ylcarbonyl)-1H-indol-5-yl ester	Investigative	644356	C20H16N2O4	348.4	COCC(=O)OC1=CC2=C(C=C1)NC(=C2)C(=O)C3=CC4=CC=CC=C4N3	IC50 ~ 100000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BCM34X	Sangivamycin	Investigative	14978	C12H15N5O5	309.28	C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)N	Ki = 67000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BML13T	GRK2 Inhibitor	Investigative	5353430	C12H9NO6	263.2	COC(=O)C1=CC=C(O1)/C=C/C2=CC=C(O2)[N+](=O)[O-]	IC50 = 126000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BR84ID	N-Benzyl-3-[(4-ethyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]benzamide	Investigative	137647477	C24H24N6O	412.5	CCN1C(=NN=C1C2=CC=NC=C2)CNC3=CC=CC(=C3)C(=O)NCC4=CC=CC=C4	EC50 = 87000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BW4AN3	[2-(1H-Indole-2-carbonyl)-1H-indol-5-yl] acetate	Investigative	5330546	C19H14N2O3	318.3	CC(=O)OC1=CC2=C(C=C1)NC(=C2)C(=O)C3=CC4=CC=CC=C4N3	IC50 ~ 100000 nM	Poor binder
T62548	Beta-adrenergic receptor kinase 1	BYZ42A	Glycine, N,N-dimethyl-, 2-(1H-indol-2-ylcarbonyl)-1H-indol-5-yl ester	Investigative	644355	C21H19N3O3	361.4	CN(C)CC(=O)OC1=CC2=C(C=C1)NC(=C2)C(=O)C3=CC4=CC=CC=C4N3	IC50 ~ 100000 nM	Poor binder